Chorokbaem Healthcare Co Ltd - Asset Resilience Ratio

Latest as of December 2025: 0.11%

Chorokbaem Healthcare Co Ltd (118000) has an Asset Resilience Ratio of 0.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Chorokbaem Healthcare Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩225.32 Million
≈ $152.70K USD Cash + Short-term Investments

Total Assets

₩197.96 Billion
≈ $134.16 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Chorokbaem Healthcare Co Ltd's Asset Resilience Ratio has changed over time. See Chorokbaem Healthcare Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Chorokbaem Healthcare Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 118000 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩225.32 Million 0.11%
Total Liquid Assets ₩225.32 Million 0.11%

Asset Resilience Insights

  • Limited Liquidity: Chorokbaem Healthcare Co Ltd maintains only 0.11% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Chorokbaem Healthcare Co Ltd Industry Peers by Asset Resilience Ratio

Compare Chorokbaem Healthcare Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
AstraZeneca PLC
LSE:AZN
Drug Manufacturers - General 0.10%
AbbVie Inc
NYSE:ABBV
Drug Manufacturers - General 0.02%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.48%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.48%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
Drug Manufacturers - General 0.46%
Korean Drug Co. Ltd
KQ:014570
Drug Manufacturers - General 12.77%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%

Annual Asset Resilience Ratio for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Chorokbaem Healthcare Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.11% ₩225.32 Million
≈ $152.70K
₩197.96 Billion
≈ $134.16 Million
+0.08pp
2024-12-31 0.03% ₩55.00 Million
≈ $37.27K
₩157.82 Billion
≈ $106.95 Million
-1.46pp
2023-12-31 1.49% ₩2.32 Billion
≈ $1.57 Million
₩155.30 Billion
≈ $105.25 Million
+0.83pp
2022-12-31 0.67% ₩1.27 Billion
≈ $858.83K
₩189.86 Billion
≈ $128.66 Million
+0.10pp
2020-12-31 0.57% ₩787.10 Million
≈ $533.41K
₩138.29 Billion
≈ $93.72 Million
-17.34pp
2019-12-31 17.91% ₩12.50 Billion
≈ $8.47 Million
₩69.80 Billion
≈ $47.31 Million
+16.05pp
2018-12-31 1.86% ₩1.14 Billion
≈ $773.15K
₩61.44 Billion
≈ $41.64 Million
-0.49pp
2017-12-31 2.35% ₩863.06 Million
≈ $584.89K
₩36.74 Billion
≈ $24.90 Million
-35.20pp
2016-12-31 37.55% ₩10.83 Billion
≈ $7.34 Million
₩28.84 Billion
≈ $19.55 Million
+36.97pp
2015-12-31 0.58% ₩94.51 Million
≈ $64.05K
₩16.41 Billion
≈ $11.12 Million
-4.36pp
2014-12-31 4.94% ₩972.03 Million
≈ $658.73K
₩19.67 Billion
≈ $13.33 Million
-3.14pp
2013-12-31 8.08% ₩1.77 Billion
≈ $1.20 Million
₩21.97 Billion
≈ $14.89 Million
--
pp = percentage points

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General
Market Cap
$16.63 Million
₩24.55 Billion KRW
Market Cap Rank
#25695 Global
#1866 in Korea
Share Price
₩1429.00
Change (1 day)
-1.99%
52-Week Range
₩222.00 - ₩2080.00
All Time High
₩13800.00
About

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more